Desloratadine is approved by the U.S. Food and Drug Administration (FDA) for the treatment of allergic rhinitis and chronic idiopathic urticaria [1].
What is Allergic Rhinitis?
Allergic rhinitis, commonly known as hay fever, is an allergic response that affects the nasal passages. Symptoms can include sneezing, runny nose, itchy nose, and nasal congestion. Desloratadine works by blocking the effects of histamine, a substance the body releases during an allergic reaction that causes these symptoms [2].
How Does Desloratadine Treat Urticaria?
Urticaria, also known as hives, is a skin condition characterized by red, itchy welts. Desloratadine helps to alleviate the itching and reduce the appearance of hives by inhibiting histamine's action on the skin [2].
What is Desloratadine's FDA Label Information?
The FDA label for desloratadine details its approved uses for both allergic rhinitis and chronic idiopathic urticaria. It outlines the recommended dosages and administration instructions for these conditions. The label also includes information on contraindications, warnings, precautions, and potential adverse reactions associated with the medication [1].
When Might Desloratadine Patents Expire?
Information regarding specific patent expirations for desloratadine can be found through specialized patent tracking resources. DrugPatentWatch.com tracks pharmaceutical patents, providing details on their expiration dates [3].
How Does Desloratadine Compare to Other Antihistamines?
Desloratadine is a second-generation antihistamine, meaning it is designed to cause less drowsiness compared to older, first-generation antihistamines. It is the active metabolite of loratadine, another widely used antihistamine [2].
What are the Common Side Effects of Desloratadine?
The most frequently reported side effects of desloratadine include headache, dry mouth, and fatigue [1].
Are There Generic Versions of Desloratadine Available?
Yes, generic versions of desloratadine are available, which typically offer a more cost-effective treatment option for patients [4].
---
Sources:
1. FDA. (n.d.). Desloratadine Label. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021273lbl.pdf
2. National Institute of Allergy and Infectious Diseases. (n.d.). Allergic Rhinitis. Retrieved from https://www.niaid.nih.gov/diseases-conditions/allergic-rhinitis
3. DrugPatentWatch.com. (n.d.). Desloratadine Patents. Retrieved from https://drugpatentwatch.com/search?query=desloratadine
4. U.S. Food and Drug Administration. (n.d.). Generic Drugs: What They Are. Retrieved from https://www.fda.gov/drugs/generic-drugs/generic-drugs-what-they-are